Search by Drug Name or NDC
NDC 49281-0400-20 Adacel 5; 5; 3; 2.5; 5; 2 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL Details
Adacel 5; 5; 3; 2.5; 5; 2 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL
Adacel is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN; BORDETELLA PERTUSSIS PERTACTIN ANTIGEN; BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXO.
MedlinePlus Drug Summary
Why get vaccinated? DTaP vaccine can prevent diphtheria, tetanus, and pertussis. Diphtheria and pertussis spread from person to person. Tetanus enters the body through cuts or wounds. DIPHTHERIA (D) can lead to difficulty breathing, heart failure, paralysis, and death. TETANUS (T) causes painful tightening of the muscles. Tetanus can lead to serious health problems, including being unable to open the mouth, having trouble swallowing and breathing, or death. PERTUSSIS (aP), also known as "whooping cough," can cause uncontrollable, violent coughing that makes it hard to breathe, eat, or drink. Pertussis can be extremely serious especially in babies and young children, causing pneumonia, convulsions, brain damage, or death. In teens and adults, it can cause weight loss, loss of bladder control, passing out, and rib fractures from severe coughing.
Related Packages: 49281-0400-20Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
Why get vaccinated? Tdap vaccine can prevent tetanus, diphtheria, and pertussis. Diphtheria and pertussis spread from person to person. Tetanus enters the body through cuts or wounds. TETANUS (T) causes painful stiffening of the muscles. Tetanus can lead to serious health problems, including being unable to open the mouth, having trouble swallowing and breathing, or death. DIPHTHERIA (D) can lead to difficulty breathing, heart failure, paralysis, or death. PERTUSSIS (aP) , also known as "whooping cough," can cause uncontrollable, violent coughing that makes it hard to breathe, eat, or drink. Pertussis can be extremely serious especially in babies and young children, causing pneumonia, convulsions, brain damage, or death. In teens and adults, it can cause weight loss, loss of bladder control, passing out, and rib fractures from severe coughing.
Related Packages: 49281-0400-20Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tetanus, Diphtheria, Pertussis (Tdap) Vaccine
Product Information
| NDC | 49281-0400 |
|---|---|
| Product ID | 49281-400_54c1ecd8-c9cc-4c58-b42d-345d03eb5e5b |
| Associated GPIs | 18990003221815 |
| GCN Sequence Number | 063698 |
| GCN Sequence Number Description | diph,pertuss(acell),tet vac/PF VIAL 2-2.5-5/.5 INTRAMUSC |
| HIC3 | W7Z |
| HIC3 Description | VACCINE/TOXOID PREPARATIONS,COMBINATIONS |
| GCN | 99416 |
| HICL Sequence Number | 035400 |
| HICL Sequence Number Description | DIPHTHERIA,PERTUSSIS(ACELLULAR),TETANUS VACCINE/PF |
| Brand/Generic | Brand |
| Proprietary Name | Adacel |
| Proprietary Name Suffix | TDaP |
| Non-Proprietary Name | CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN ( |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SUSPENSION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 5; 5; 3; 2.5; 5; 2 |
| Active Ingredient Units | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL |
| Substance Name | BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN; BORDETELLA PERTUSSIS PERTACTIN ANTIGEN; BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXO |
| Labeler Name | Sanofi Pasteur Inc. |
| Pharmaceutical Class | Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordet |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125111 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49281-0400-20 (49281040020)
| NDC Package Code | 49281-400-20 |
|---|---|
| Billing NDC | 49281040020 |
| Package | 5 SYRINGE in 1 PACKAGE (49281-400-20) / .5 mL in 1 SYRINGE (49281-400-89) |
| Marketing Start Date | 2005-06-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |